Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Von Willebrand factor (VWF) fragments are proteolytically or recombinantly generated portions of the full-length VWF protein. They retain specific biological activities depending on which domains are present, such as mediating platelet adhesion, binding collagen, or stabilizing factor VIII. These fragments are clinically relevant in von Willebrand disease diagnosis and potentially as therapeutic agents.
Mediate platelet adhesion via interaction with GPIbα, bind collagen or integrins depending on included domains, and/or stabilize circulating factor VIII if containing the D′D3 region.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand Factor Fragment (VWF Fragment).